Advertisement

International Journal of Clinical Pharmacy

, Volume 41, Issue 5, pp 1202–1209 | Cite as

Exploring variables associated with medication non-adherence in patients with COPD

  • Anan S. JarabEmail author
  • Tareq L. Mukattash
Research Article
  • 180 Downloads

Abstract

Background: Research has indicated that medication adherence is low and represents a barrier to achieve the desired health outcome in patients with Chronic Obstructive Pulmonary Disease (COPD). Objective: The aim of the study was to investigate the factors that are significantly associated with self-reported medication non-adherence in patients with COPD. Setting: Patients attending the outpatient respiratory clinic at the Royal Medical Services (RMS) Hospital in Amman. In addition to socio-demographics, validated measures including COPD knowledge questionnaire, the 4-item self-reported Morisky medication adherence scale, St George respiratory questionnaire and Health Anxiety and Depression scale were used in the present study. The stepwise logistic regression analysis was performed in order to identify variables that independently and significantly predicted medication non-adherence. Main outcome measure: Predictors of medication non-adherence. Results: A total of 133 patients participated in the study. Results indicated that majority of the patients (61.7%) were non-adherent. According to the model, patients were four times more likely to be non-adherent if they reported having depression (OR 0.251, CI 0.24–0.76) and approximately eight times to have medication non-adherence if they suffered from comorbid illness (OR 0.119, CI 0.11–0.80). Study participants were found to have a double risk of medication nonadherence if they received an increase in the frequency of administration of their COPD medication (OR 0.524, CI 0.08–0.69) and being concerned about side effects (OR 0.515, CI 0.36–0.92). Conclusion: Depression, dosage regimen complexity, the presence of co-morbidities and therapy side effects have significantly influenced adherence to COPD therapy in the present study. Clinical pharmacists should provide emotional support, simplify dosage regimen, use adherence aids, elicit patients' concerns about their illness comorbidities, select treatments with less side effect and help the patients coping with side effects in order to enhance adherence and health outcomes in patients with COPD.

Keywords

COPD Chronic obstructive pulmonary disease Jordan Medication adherence Pharmaceutical care Predictors 

Notes

Acknowledgement

The authors wish to thank the COPD specialist Nurse for her support in patient’s identification and recruitment.

Funding

There was no external funding for this study.

Conflicts of interests

None to declare.

References

  1. 1.
    Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    GOLD. global initiative for chronic obstructive lung disease. Updated 2008. http://www.goldcopd.com.
  3. 3.
    Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–84.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Serra-Batlles J, Plaza V, Badiola C, Morejón E. Inhalation Devices Study Group. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med. 2002;15(1):59–64.PubMedCrossRefGoogle Scholar
  5. 5.
    Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijk JT. Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scand J Prim Health Care. 2001;19(54):255–60.PubMedGoogle Scholar
  6. 6.
    World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva: WHO; 2003.Google Scholar
  7. 7.
    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.PubMedCrossRefGoogle Scholar
  8. 8.
    Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999;93(2):88–94.PubMedCrossRefGoogle Scholar
  10. 10.
    Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest. 1998;113(3):587–92.PubMedCrossRefGoogle Scholar
  11. 11.
    Mapel DW, Picchi MA, Hurley JS, Frost FJ, Petersen HV, Mapel VM, et al. Utilization in COPD: patient characteristics and diagnostic evaluation. Chest. 117(5 Suppl 2):346S-53S.Google Scholar
  12. 12.
    van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax. 2002;57(5):412–6.Google Scholar
  13. 13.
    Dalon F, Van Ganse E. Correia Da Silva C, Nachbaur G, Saïl L, Belhassen M. Therapeutic adherence in chronic obstructive pulmonary disease: a literature review Rev Mal Respir. 2019.  https://doi.org/10.1016/j.rmr.2019.06.005.CrossRefPubMedGoogle Scholar
  14. 14.
    Bryant J, McDonald VM, Boyes A, Sanson-Fisher R, Paul C, Melville J. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2013;14:109.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Scherer YK, Schmieder LE, Shimmel S. The effects of education alone and in combination with pulmonary rehabilitation on self-efficacy in patients with COPD. Rehabil Nurs. 1996;23(2):71–7.CrossRefGoogle Scholar
  16. 16.
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med care. 1986;24(1):67–74.PubMedCrossRefGoogle Scholar
  17. 17.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–70.CrossRefGoogle Scholar
  18. 18.
    Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.PubMedCrossRefGoogle Scholar
  19. 19.
    Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Spencer S, Calverley PM, Sherwood Burge P, Jones PW, ISOLDE Study Group. Inhaled steroids in obstructive lung disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:122–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Jones PW, Quirk FH, Baveystock CM. The St. George’s Respiratory Questionnaire. Respir Med. 1991;85(Suppl. B):25–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Field A. Discovering statistics using SPSS. 2nd ed. London: Sage; 2000.Google Scholar
  23. 23.
    NICE Guideline - COPD in over 16s: diagnosis and management" (2018). https://www.nice.org.uk/guidance/ng115.
  24. 24.
    Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley- Interscience Publication; 2000.CrossRefGoogle Scholar
  25. 25.
    Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J. 2000;16(6):1037–42.PubMedCrossRefGoogle Scholar
  26. 26.
    George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198–204.PubMedCrossRefGoogle Scholar
  27. 27.
    Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Int Med. 2002;17(10):749–55.CrossRefGoogle Scholar
  28. 28.
    Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: analyzing factors associated with a successful treatment. Pulmonology. 2019.  https://doi.org/10.1016/j.pulmoe.2019.05.012.CrossRefPubMedGoogle Scholar
  29. 29.
    Humenberger M, Horner A, Labek A, Kaiser B, Frechinger R, Brock C, Lichtenberger P, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Wiśniewski D, Porzezińska M, Gruchała-Niedoszytko M, Niedoszytko M, Słomiński JM, Jassem E. Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol Alergol Pol. 2014;82(2):96–104.PubMedCrossRefGoogle Scholar
  31. 31.
    Mohsen S, Hanafy FZ, Fathy AA, El-Gilany AH. Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease. Lung India. 2019;36(3):193–8.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Barja-Martínez E, Casas-González S, Simón-López AF, Mancheño-Ovejero C, Padial-de la Cruz MLG. Adherence to inhaled therapy in the outpatient setting. Enferm Clin. 2019;29(1):34–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: understanding patients' adhereunce to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–73.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Jarab AS, Alqudah S. Khdour M, Shamssain M, Mukattash T. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62.PubMedCrossRefGoogle Scholar
  35. 35.
    Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012;68(10):1365–73.PubMedCrossRefGoogle Scholar
  36. 36.
    Ágh T, Inotai A, Mészáros Á. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. 2011;82(4):328–34.PubMedCrossRefGoogle Scholar
  37. 37.
    Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32(6):603–11.PubMedCrossRefGoogle Scholar
  38. 38.
    Krigsman K, Nilsson JL, Ring L. Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication. Pharmacoepidemiol Drug Saf. 2007;16(10):1120–8.PubMedCrossRefGoogle Scholar
  39. 39.
    American Lung Association (ALA). American lung association fact sheet: chronic obstructive pulmonary disease; 2006. Available from https://www.Lungusa.org/diseases/copd_factsheet.
  40. 40.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A Jr, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? meta-analysis of published reports. BMJ. 2002;325(7370):925.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depuressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246–52.PubMedCrossRefGoogle Scholar
  43. 43.
    DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(4):521–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Kampman O, Laippala P, Väänänen J, Koivisto E, Kiviniemi P, Kilkku N, et al. Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002;110(1):39–48.PubMedCrossRefGoogle Scholar
  45. 45.
    Nasser EH, Overholser JC. Recovery from major depression: the role of support from family, friends, and spiritual beliefs. Acta Psychiatr Scand. 2005;111(2):125–32.PubMedCrossRefGoogle Scholar
  46. 46.
    Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Resp Med. 2011;105(3):435–41.CrossRefGoogle Scholar
  47. 47.
    Prajapati R, Shrestha S. Medication adherence and its associated factors among COPD patients attending medical OPD of Dhulikhel hospital. Nepal IJNRP. 2015;2(1):15–9.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Clinical Pharmacy, Faculty of PharmacyJordan University of Science and TechnologyIrbidJordan

Personalised recommendations